p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5333-5344

  Harada, Josephine N ^a   Berk, Arnold J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E1B 55K; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS MESSENGER RNA; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA REPLICATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSLATION; RNA TRANSPORT; STRAIN DIFFERENCE; TEMPERATURE SENSITIVITY; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0033022039     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5333-5344.1999     Document Type: Article

References (89)

1. Arrigo, S. J., and I. S. Y. Chen. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:808-819.
2. Babiss, L. E., and H. S. Ginsberg. 1984. Adenovirus type 5 early region 1B gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50:202-212.
3. Babiss, L. E., H. S. Ginsberg, and J. E. Darnell. 1985. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5:2552-2558.
4. Baker, S. J., S. Markowitz, E. R Fearon, J. K. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
5. Barker, D. D., and A. J. Berk. 1988. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 56:107-121.
6. Beltz, G. A., and S. J. Flint. 1979. Inhibition of HeLa cell protein synthesis during adenovirus infection. J. Mol. Biol. 131:353-373.
7. Berk, A. J. 1989. Characterization of RNA molecules by S1 nuclease analysis. Methods Enzymol. 180:334-347.
8. Berk, A. J., and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell 12:721-732.
9. Berkner, K. L., and P. A. Sharp. 1985. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Res. 13:841-857.
10. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
11. Bressac, B., K. M. Galvin, T. J. Liang, K. J. Isselbacher, J. R. Wands, and M. Ozturk. 1990. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:1973-1977.
12. Bridge, E., and G. Ketner. 1990. Interaction of adenoviral E4 and E1b products in late gene expression. Virology 174:345-353.
13. Carroll, A. G., H. J. Voeller, L. Sugars, and E. P. Gelmann. 1993. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23:123-134.
14. Castrillo, J. L., and L. Carrasco. 1987. Adenovirus late protein synthesis is resistant to the inhibition of translation induced by poliovirus. J. Biol. Chem. 262:7328-7334.
15. Chandar, N., B. Bilig, J. McMaster, and J. Novak. 1992. Inactivation of p53 gene in human and murine osteosarcoma cells. Br. J. Cancer 65:208-214.
16. Chiou, S.-K., C.-C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
17. Chiou, S.-K., and E. White. 1997. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:3515-3525.
18. Crook, T., D. Wrede, and K. H. Vousden. 1991. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873-875.
19. D'Agostino, D. M., B. K. Felber, J. E. Harrison, and G. N. Pavlakis. 1992. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpr/env mRNAs. Mol. Cell. Biol. 12:1375-1386.
20. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
21. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Barker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
22. Dobbelstein, M., J. Roth, W. T. Kimberly, A. J. Levine, and T. Shenk. 1997. Nuclear export of the E1b-55kDa and E4-34kDa adenoviral oncoproteins mediated by a rev-like signal sequence. EMBO J. 16:4276-4284.
23. Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473.
24. Dolph, P. J., J. Huang, and R. J. Schneider. 1990. Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex. J. Virol. 64:2669-2677.
25. Dolph, R. J., V. Racaniello, A. Villamarin, F. Palladino, and R. J. Schneider. 1988. The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. J. Virol. 62:2059-2066.
26. Farshid, M., and E. Tabor. 1992. Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastome cell lines. J. Med. Virol. 38:235-239.
27. Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
28. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
29. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653-8659.
30. Reference deleted.
31. Goodrum, F. D., and D. A. Ornelles. 1997. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol. 71:548-561.
32. Goodrum, F. D., and D. A. Ornelles. 1998. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J. Virol. 72:9479-9490.
33. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
34. Grand, R. J. A., M. L. Grant, and P. H. Gallimore. 1994. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229-240.
35. Halbert, D. N., and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
36. Hall, A. R., B. R. Dix, S. J. O'Carroll, and A. W. Braithwaite. 1998. p53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nat. Med. 4:1068-1072.
37. Harrison, T., F. Graham, and J. Williams. 1977. Host-range mutants of adenovirus type 5 defective for growth in HeLa cells. Virology 77:319-329.
38. Hayes, B. W., G. C. Telling, M. M. Myat, J. F. Williams, and S. J. Flint. 1990. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64:2732-2742.
39. Heise, C., A. Sampson-Johannes, A. Williams, F. McCormick, D. D. V. Hoff, and D. H. Kirn. 1997. ONYX-015, an E1B gene attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:639-645.
40. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
41. Ho, Y. S., R. Galos, and J. Williams. 1982. Isolation of the type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function. Virology 122:109-124.
42. Huang, J., and R. J. Schneider. 1991. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell 65:271-280.
43. Imperiale, M. J., G. Akusjarvi, and K. N. Leppard. 1995. Post-transcriptional control of adenovirus gene expression. Curr. Top. Microbiol. Immunol. 199: 139-171.
44. Joshi-Barve, S., W. Rychlik, and R. E. Rhoads. 1990. Alteration of the major phosphorylation site of eukaryotic protein synthesis initiation factor 4E prevents its association with the 48S initiation complex. J. Biol. Chem. 245:2979-2983.
45. Kao, C. C., P. R. Yew, and A. J. Berk. 1990. Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 179:806-814.
46. Kaspar, R. L., W. Rychlik, M. W. White, R. E. Rhoads, and D. R. Morris. 1990. Simultaneous cytoplasmic redistribution of ribosomal protein L32 mRNA and phosphorylation of eukaryotic initiation factor 4E after mitogenic stimulation of Swiss 3T3 cells. J. Biol. Chem. 265:3619-3622.
47. Lamphear, B. J., and R. Panniers. 1991. Heat shock impairs the interaction of cap-binding protein complex with 5′ mRNA cap. J. Biol. Chem. 266:2789-2794.
48. Lane, D. P. 1998. Killing tumor cells with viruses - a question of specificity. Nat. Med. 4:1012-1013.
49. Lehman, T. A., W. P. Bennett, R. A. Metcalf, J. A. Welsh, J. Ecker, R. V. Modali, S. Ullrich, J. W. Romano, E. Appella, J. R. Testa, B. I. Gerwin, and C. C. Harris. 1991. p53 mutations, ras mutations, and p53-heat shock protein complexed in human lung carcinoma cell lines. Cancer Res. 51:4090-4096.
50. Leppard, K. N., and T. Shenk. 1989. The adenovirus E1B 55 kD protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8:2329-2336.
51. Levine, A. J. 1997. p53, the gatekeeper for growth and division. Cell 88:323-331.
52. Linke, S. P. 1998. Has the smart bomb been defused? Nature 395:13-15.
53. Logan, J., and T. Shenk. 1984. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc. Natl. Acad. Sci. USA 81:3655-3659.
54. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus E1A and accompanies apoptosis. Genes Dev. 7:535-545.
55. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257.
56. Martin, M. E. D., and A. J. Berk. 1998. Adenovirus E1B-55K represses p53 activation in vitro. J. Virol. 72:3146-3154.
57. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
58. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
59. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, H. K. Bodner, H. K. Oie, R. I. Rinnoila, J. L. Mulshine, J. D. Minna, and A. F. Gazdar. 1992. p53 gene mutations in non-small-lung cell cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
60. Moore, M., N. Horikoshi, and T. Shenk. 1996. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 93:11295-11301.
61. Nakielny, S., U. Fischer, W. M. Michael, and G. Dreyfuss. 1997. RNA transport. Annu. Rev. Neurosci. 20:269-301.
62. Nevels, M., S. Rubenwolf, T. Spruss, H. Wolf, and T. Dobner. 1997. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc. Natl. Acad. Sci. USA 94:1206-1211.
63. Ornelles, D. A., and T. Shenk. 1991. Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J. Virol. 65:424-439.
64. Pilder, S., K. Leppard, J. Logan, and T. Shenk. 1986. Functional analysis of the adenovirus E1B 55K polypeptide. Cancer Cells. 4:285-290.
65. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
66. Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner, and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71: 3788-3798.
67. Querido, E., J. G. Teodoro, and P. E. Branton. 1997. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol. 71:3526-3533.
68. Rao, L., M. Debbas, D. Sabbatini, D. Hockenberry, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
69. Ridgway, P. J., A. R. Hall, C. J. Myers, and A. W. Braithwaite. 1997. p53/ E1b58kDa complex regulates adenovirus replication. Virology 237:404-413.
70. Roth, J., C. Konig, S. Weinzer, S. Weigel, S. Ristea, and M. Dobbelstein. 1998. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol. 72:8510-8516.
71. Rothmann, T., A. Hengstermann, N. J. Whitaker, M. Sheffner, and H. Z. Hausen. 1998. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72:9470-9478.
72. Rubenwolf, S., H. Schutt, M. Nevels, H. Wolf, and T. Dobner. 1997. Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex. J. Virol. 71:1115-1123.
73. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
74. Sarnow, P., P. Hearing, C. W. Anderson, D. N. Halbert, T. Shenk, and A. J. Levine. 1984. Adenovirus early-region 1B 58,000-dalton tumor antigen is physically associated with an early-region 4 25,000-dalton protein in productively infected cells. J. Virol. 49:692-700.
75. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of p53 and retinoblastoma genes in human cervical cancer cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
76. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human pappillomavirus types 15 and 18 promotes the degradation of p53. Cell 63:1129-1136.
77. Schneider, R. J. 1995. Cap-independent translation in adenovirus infected cells. Curr. Top. Microbiol. Immunol. 203:117-129.
78. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
79. Slebos, R. J. C., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M. B. Kastan, and K. R. Cho. 1994. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91:5320-5324.
80. Slichenmyer, W. J., W. G. Nelson, R. J. Slebos, and M. B. Kastan. 1993. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53:4164-4168.
81. Steegenga, W. T., N. Riteco, A. G. Jochemsen, F. J. Fallaux, and J. L. Bos. 1998. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16:349-357.
82. Turnell, A. S., R. J. A. Grand, and P. H. Gallimore. 1999. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status. J. Virol. 73:2074-2083.
83. White, E. 1995. Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Top. Microbiol. Immunol. 199:34-57.
84. Williams, J., B. D. Karger, Y. S. Ho, C. L. Castaglia, T. Mann, and S. J. Flint. 1986. The adenovirus E1B 495R protein plays a role in regulating the transport and stability of the viral late messages. Cancer Cells 4:275-284.
85. Yaginuma, Y., and H. Westphal. 1992. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res. 52:4196-4199.
86. Yew, P. R., and A. J. Berk. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82-85.
87. Yew, P. R., C. C. Kao, and A. J. Berk. 1990. Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis. Virology 179:795-805.
88. Yew, P. R., X. Liu, and A. J. Berk. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190-202.
89. Zhang, Y., D. Feigenblum, and R. J. Schneider. 1994. A late adenovirus factor induced eIF-4E dephosphorylation and inhibition of cell protein synthesis. J. Virol. 68:7040-7050.